Pacific Historical Balance Sheet

PACB Stock

USD 1.39 0.06 4.51%

Trend analysis of Pacific Biosciences of balance sheet accounts such as Total Current Liabilities of 50.3 M, Total Stockholder Equity of 531.9 M, Other Liabilities of 2.8 M or Property Plant And Equipment Net of 36.4 M provides information on Pacific Biosciences' total assets, liabilities, and equity, which is the actual value of Pacific Biosciences to its prevalent stockholders. By breaking down trends over time using Pacific Biosciences balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Pacific Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Pacific Biosciences is a good buy for the upcoming year.

Pacific Biosciences Inventory

61.69 Million

Build AI portfolio with Pacific Stock

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pacific Biosciences of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

About Pacific Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Pacific Biosciences at a specified time, usually calculated after every quarter, six months, or one year. Pacific Biosciences Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Pacific Biosciences and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Pacific currently owns. An asset can also be divided into two categories, current and non-current.

Pacific Biosciences Balance Sheet Chart

At present, Pacific Biosciences' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Total Assets is expected to grow to about 1.3 B, whereas Total Current Liabilities is forecasted to decline to about 50.3 M.

Common Stock Shares Outstanding Total Assets Short Long Term Debt Total Other Current Liab

Add Fundamental

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Total Assets

Total assets refers to the total amount of Pacific Biosciences assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Pacific Biosciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Most accounts from Pacific Biosciences' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Pacific Biosciences current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pacific Biosciences of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	957.4M	933.9M	672.4M	706.1M
Total Assets	1.8B	1.7B	1.3B	1.3B

Short Long Term Debt Total Total Assets

Pacific Biosciences balance sheet Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Property Plant Equipment
Common Stock Shares Outstanding		0.81	0.82	0.43	0.53	0.84	0.14	0.75	0.5	0.89	-0.98	0.91	0.38	0.86	0.55	0.05	0.62	0.7	0.77	0.92	0.99	0.77	0.96	0.66	0.4	0.94
Total Assets	0.81		0.99	0.65	0.71	0.97	0.46	0.78	0.6	0.94	-0.77	0.77	0.79	0.98	0.42	-0.1	0.93	0.95	0.99	0.78	0.86	0.99	0.82	0.95	0.21	0.9
Short Long Term Debt Total	0.82	0.99		0.67	0.73	0.94	0.39	0.76	0.64	0.97	-0.8	0.81	0.75	1.0	0.46	-0.15	0.89	0.91	0.99	0.8	0.87	0.99	0.84	0.91	0.26	0.92
Other Current Liab	0.43	0.65	0.67		0.98	0.55	0.05	0.63	0.84	0.59	-0.4	0.37	0.65	0.63	0.31	0.19	0.66	0.63	0.63	0.37	0.45	0.7	0.38	0.67	0.17	0.52
Total Current Liabilities	0.53	0.71	0.73	0.98		0.62	0.06	0.66	0.88	0.68	-0.51	0.49	0.64	0.7	0.42	0.18	0.7	0.69	0.68	0.45	0.56	0.75	0.47	0.71	0.24	0.6
Total Stockholder Equity	0.84	0.97	0.94	0.55	0.62		0.47	0.78	0.53	0.9	-0.79	0.75	0.73	0.94	0.41	0.0	0.91	0.95	0.92	0.78	0.89	0.91	0.84	0.93	0.17	0.89
Other Liab	0.14	0.46	0.39	0.05	0.06	0.47		0.38	-0.01	0.21	-0.04	0.09	0.74	0.34	-0.27	-0.14	0.65	0.56	0.48	0.02	0.17	0.44	0.09	0.61	0.04	0.25
Property Plant And Equipment Net	0.75	0.78	0.76	0.63	0.66	0.78	0.38		0.49	0.68	-0.66	0.61	0.71	0.74	0.21	0.2	0.79	0.8	0.74	0.53	0.71	0.75	0.72	0.8	0.47	0.74
Current Deferred Revenue	0.5	0.6	0.64	0.84	0.88	0.53	-0.01	0.49		0.6	-0.52	0.45	0.51	0.61	0.52	0.19	0.56	0.57	0.57	0.41	0.54	0.63	0.41	0.58	0.2	0.49
Net Debt	0.89	0.94	0.97	0.59	0.68	0.9	0.21	0.68	0.6		-0.89	0.89	0.56	0.99	0.55	-0.2	0.77	0.82	0.94	0.9	0.93	0.94	0.92	0.8	0.27	0.95
Retained Earnings	-0.98	-0.77	-0.8	-0.4	-0.51	-0.79	-0.04	-0.66	-0.52	-0.89		-0.93	-0.28	-0.84	-0.62	0.03	-0.54	-0.64	-0.73	-0.93	-0.98	-0.73	-0.95	-0.59	-0.4	-0.93
Accounts Payable	0.91	0.77	0.81	0.37	0.49	0.75	0.09	0.61	0.45	0.89	-0.93		0.32	0.85	0.64	-0.21	0.53	0.6	0.76	0.87	0.93	0.75	0.91	0.57	0.48	0.93
Cash	0.38	0.79	0.75	0.65	0.64	0.73	0.74	0.71	0.51	0.56	-0.28	0.32		0.69	0.06	0.03	0.93	0.85	0.79	0.26	0.42	0.8	0.36	0.91	0.11	0.53
Non Current Assets Total	0.86	0.98	1.0	0.63	0.7	0.94	0.34	0.74	0.61	0.99	-0.84	0.85	0.69		0.5	-0.17	0.86	0.89	0.98	0.85	0.91	0.98	0.88	0.88	0.25	0.94
Non Currrent Assets Other	0.55	0.42	0.46	0.31	0.42	0.41	-0.27	0.21	0.52	0.55	-0.62	0.64	0.06	0.5		0.22	0.21	0.3	0.39	0.51	0.59	0.41	0.51	0.26	0.25	0.5
Other Assets	0.05	-0.1	-0.15	0.19	0.18	0.0	-0.14	0.2	0.19	-0.2	0.03	-0.21	0.03	-0.17	0.22		0.02	0.04	-0.2	-0.16	-0.03	-0.15	-0.11	0.02	0.06	-0.16
Cash And Short Term Investments	0.62	0.93	0.89	0.66	0.7	0.91	0.65	0.79	0.56	0.77	-0.54	0.53	0.93	0.86	0.21	0.02		0.98	0.91	0.54	0.67	0.92	0.61	1.0	0.13	0.72
Short Term Investments	0.7	0.95	0.91	0.63	0.69	0.95	0.56	0.8	0.57	0.82	-0.64	0.6	0.85	0.89	0.3	0.04	0.98		0.91	0.63	0.75	0.92	0.7	0.99	0.13	0.78
Non Current Liabilities Total	0.77	0.99	0.99	0.63	0.68	0.92	0.48	0.74	0.57	0.94	-0.73	0.76	0.79	0.98	0.39	-0.2	0.91	0.91		0.76	0.82	1.0	0.8	0.93	0.22	0.89
Other Current Assets	0.92	0.78	0.8	0.37	0.45	0.78	0.02	0.53	0.41	0.9	-0.93	0.87	0.26	0.85	0.51	-0.16	0.54	0.63	0.76		0.93	0.75	0.94	0.58	0.18	0.91
Other Stockholder Equity	0.99	0.86	0.87	0.45	0.56	0.89	0.17	0.71	0.54	0.93	-0.98	0.93	0.42	0.91	0.59	-0.03	0.67	0.75	0.82	0.93		0.82	0.96	0.71	0.34	0.96
Total Liab	0.77	0.99	0.99	0.7	0.75	0.91	0.44	0.75	0.63	0.94	-0.73	0.75	0.8	0.98	0.41	-0.15	0.92	0.92	1.0	0.75	0.82		0.79	0.93	0.23	0.88
Property Plant And Equipment Gross	0.96	0.82	0.84	0.38	0.47	0.84	0.09	0.72	0.41	0.92	-0.95	0.91	0.36	0.88	0.51	-0.11	0.61	0.7	0.8	0.94	0.96	0.79		0.65	0.35	0.94
Total Current Assets	0.66	0.95	0.91	0.67	0.71	0.93	0.61	0.8	0.58	0.8	-0.59	0.57	0.91	0.88	0.26	0.02	1.0	0.99	0.93	0.58	0.71	0.93	0.65		0.15	0.76
Short Term Debt	0.4	0.21	0.26	0.17	0.24	0.17	0.04	0.47	0.2	0.27	-0.4	0.48	0.11	0.25	0.25	0.06	0.13	0.13	0.22	0.18	0.34	0.23	0.35	0.15		0.29
Property Plant Equipment	0.94	0.9	0.92	0.52	0.6	0.89	0.25	0.74	0.49	0.95	-0.93	0.93	0.53	0.94	0.5	-0.16	0.72	0.78	0.89	0.91	0.96	0.88	0.94	0.76	0.29

Click cells to compare fundamentals

Pacific Biosciences Account Relationship Matchups

Pacific Biosciences balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Common Stock Shares Outstanding	175.0M	204.1M	224.6M	253.6M	288.4M	302.8M
Total Assets	414.0M	2.0B	1.8B	1.7B	1.3B	1.3B
Short Long Term Debt Total	42.0M	955.4M	957.4M	933.9M	672.4M	706.1M
Other Current Liab	17.5M	40.4M	203.2M	53.5M	14.9M	24.9M
Total Current Liabilities	38.5M	71.7M	263.3M	95.0M	66.3M	50.3M
Total Stockholder Equity	335.5M	791.0M	562.9M	701.3M	506.6M	531.9M
Other Liab	2.0M	10.3M	215.0M	2.6M	3.0M	2.8M
Property Plant And Equipment Net	54.9M	79.1M	81.3M	69.0M	46.6M	36.4M
Current Deferred Revenue	8.7M	11.0M	32.3M	16.3M	13.9M	11.4M
Net Debt	(39.6M)	494.6M	632.3M	754.0M	617.1M	647.9M
Retained Earnings	(1.0B)	(1.2B)	(1.5B)	(1.8B)	(2.1B)	(2.0B)
Accounts Payable	3.6M	11.0M	12.0M	15.1M	16.6M	17.4M
Cash	81.6M	460.7M	325.1M	179.9M	55.4M	52.6M
Non Current Assets Total	58.4M	905.8M	915.0M	1.0B	764.8M	803.0M
Non Currrent Assets Other	3.5M	1.2M	10.5M	13.3M	10.8M	11.4M
Other Assets	33.5M	1.2M	13.5M	1.0	1.15	1.09
Cash And Short Term Investments	318.8M	1.0B	772.3M	631.4M	389.9M	291.2M
Short Term Investments	237.2M	583.7M	447.2M	451.5M	334.6M	181.1M
Liabilities And Stockholders Equity	414.0M	2.0B	1.8B	1.7B	1.3B	1.3B
Non Current Liabilities Total	40.0M	1.1B	940.8M	949.7M	687.6M	721.9M
Other Current Assets	5.7M	7.9M	10.6M	14.3M	19.5M	20.4M
Other Stockholder Equity	1.4B	2.0B	2.1B	2.5B	2.7B	2.8B
Total Liab	78.5M	1.2B	1.2B	1.0B	753.9M	791.5M
Property Plant And Equipment Gross	54.9M	79.1M	81.3M	143.8M	128.5M	135.0M
Total Current Assets	355.6M	1.1B	852.1M	742.0M	495.7M	332.1M
Accumulated Other Comprehensive Income	85K	(1.1M)	(4.8M)	219K	422K	443.1K
Short Term Debt	4.3M	9.3M	10.7M	10.1M	10.0M	7.8M
Property Plant Equipment	30.1M	24.9M	79.1M	81.3M	93.5M	98.2M
Net Receivables	16.8M	24.2M	18.8M	36.6M	27.5M	14.1M
Common Stock Total Equity	150K	153K	192K	221K	198.9K	189.0K
Inventory	14.2M	24.6M	50.4M	56.7M	58.8M	61.7M
Common Stock	192K	221K	227K	268K	294K	279.3K
Net Tangible Assets	54.9M	335.5M	(30.0M)	(257.3M)	(231.6M)	(220.0M)
Retained Earnings Total Equity	(982.1M)	(1.1B)	(1.0B)	(1.2B)	(1.1B)	(1.2B)
Non Current Liabilities Other	40.0M	178.9M	180.6M	20.3M	19.2M	18.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

USOI	Credit Suisse X Links
ULTY	Tidal Trust II
CONY	YieldMax N Option

When determining whether Pacific Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Pacific Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pacific Biosciences Of Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pacific Biosciences Of Stock:

How To Invest In Pacific

Details

Is Pacific Stock a good investment?

Details

What is Pacific Biosciences' Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pacific Biosciences. If investors know Pacific will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pacific Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.74)

Revenue Per Share

0.542

Quarterly Revenue Growth

(0.04)

Return On Assets

(0.32)

Return On Equity

(1.78)

The market value of Pacific Biosciences is measured differently than its book value, which is the value of Pacific that is recorded on the company's balance sheet. Investors also form their own opinion of Pacific Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Pacific Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pacific Biosciences' market value can be influenced by many factors that don't directly affect Pacific Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Pacific Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pacific Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pacific Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC

Pacific Historical Balance Sheet

Pacific Biosciences Inventory

61.69 Million

About Pacific Balance Sheet Analysis

Pacific Biosciences Balance Sheet Chart

Common Stock Shares Outstanding

Total Assets

Pacific Biosciences balance sheet Correlations

Pacific Biosciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Pacific Biosciences balance sheet Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Short Long Term Debt Total
Total Current Assets	+ 1.0	Cash And Short Term Investments
Total Liab	+ 1.0	Non Current Liabilities Total
Other Stockholder Equity	+ 0.99	Common Stock Shares Outstanding
Short Long Term Debt Total	+ 0.99	Total Assets
Non Current Liabilities Total	+ 0.99	Total Assets

Other Stockholder Equity	- 0.98	Retained Earnings
Retained Earnings	- 0.98	Common Stock Shares Outstanding
Property Plant And Equipment Gross	- 0.95	Retained Earnings
Property Plant Equipment	- 0.93	Retained Earnings
Other Current Assets	- 0.93	Retained Earnings
Accounts Payable	- 0.93	Retained Earnings